Jhiang S M, Sagartz J E, Tong Q, Parker-Thornburg J, Capen C C, Cho J Y, Xing S, Ledent C
Department of Physiology and Internal Medicine, Ohio State University, Columbus 43210, USA.
Endocrinology. 1996 Jan;137(1):375-8. doi: 10.1210/endo.137.1.8536638.
The ret/PTC oncogene, a rearranged form of the ret proto-oncogene, has been found to be restricted to human papillary thyroid carcinomas. This report shows that transgenic mice with thyroid-targeted expression of the ret/PTC1 oncogene developed thyroid carcinomas with considerable similarities to human papillary thyroid carcinomas, particularly in the nuclear cytologic features and the presence of local invasion. Our findings indicate that ret/PTC2 is not only a biomarker associated with papillary thyroid carcinomas, but is also the only proven specific genetic event leading to the development of papillary thyroid carcinoma.
ret/PTC癌基因是原癌基因ret的一种重排形式,已发现其仅存在于人类甲状腺乳头状癌中。本报告显示,甲状腺靶向表达ret/PTC1癌基因的转基因小鼠发生了甲状腺癌,这些癌与人类甲状腺乳头状癌有相当多的相似之处,特别是在细胞核细胞学特征和局部浸润方面。我们的研究结果表明,ret/PTC2不仅是与甲状腺乳头状癌相关的生物标志物,而且是导致甲状腺乳头状癌发生的唯一已证实的特定基因事件。